Acelrx Pharmaceuticals Current Cash

Acelrx Pharmaceuticals (ACRX) currently reports a current cash of $740K as of June 2026. That compares with $6.8M in the prior-year period — down 89.1% year over year. Use the charts on this page to explore Acelrx Pharmaceuticals's current cash history and peer comparisons.

Acelrx Pharmaceuticals's current cash decreased from $6.8M to $740K — a 89.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acelrx Pharmaceuticals reported $740K in current cash as of June 2026. That compares with $6.8M in the prior-year period — down 89.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $740K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acelrx Pharmaceuticals, and consider following ACRX for alerts when major investors trade the stock.

Acelrx Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $740K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACRX with unrelated industries.